A Study of Safety, Tolerability, and the Effects Two ND-L02-s0201 Have on the Body

NCT03241264 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb

Collaborators